231 related articles for article (PubMed ID: 21815443)
1. Cutaneous manifestations of connective tissue disease.
McCammack E; Haggstrom AN
Adolesc Med State Art Rev; 2011 Apr; 22(1):35-53. PubMed ID: 21815443
[TBL] [Abstract][Full Text] [Related]
2. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
Hom C; Ilowite NT
Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
[TBL] [Abstract][Full Text] [Related]
3. Innovative management of lupus erythematosus.
Knott HM; Martínez JD
Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
[TBL] [Abstract][Full Text] [Related]
4. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
Momose Y; Arai S; Eto H; Kishimoto M; Okada M
J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus.
Grönhagen CM; Gunnarsson I; Svenungsson E; Nyberg F
Lupus; 2010 Sep; 19(10):1187-94. PubMed ID: 20501526
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma.
Hansen CB; Callen JP
Dermatol Ther; 2010; 23(4):341-9. PubMed ID: 20666821
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
[TBL] [Abstract][Full Text] [Related]
8. Management of skin disease in lupus.
Callen JP
Bull Rheum Dis; 1997 Apr; 46(2):4-7. PubMed ID: 9104044
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestations of selected rheumatologic diseases.
Ostezan LB; Callen JP
Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic approach and treatment of cutaneous lupus erythematosus.
Sticherling M; Bonsmann G; Kuhn A
J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of hydroxychloroquine on cutaneous lupus erythematosus in a Japanese girl.
Yamamoto T; Hiraiwa T
J Dermatol; 2014 Apr; 41(4):357-9. PubMed ID: 24617496
[No Abstract] [Full Text] [Related]
14. Discoid lupus erythematosus in a teenager.
Hong J; Cordoro KM
J Pediatr; 2011 Aug; 159(2):350. PubMed ID: 21592497
[No Abstract] [Full Text] [Related]
15. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
16. A rare case of unilateral discoid lupus erythematosus mimicking lupus vulgaris.
Verma P; Pathania S; Kubba A
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29122902
[TBL] [Abstract][Full Text] [Related]
17. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
19. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
[TBL] [Abstract][Full Text] [Related]
20. Recognition and Management of Cutaneous Connective Tissue Diseases.
Kus KJB; LaChance AH; Vleugels RA
Med Clin North Am; 2021 Jul; 105(4):757-782. PubMed ID: 34059249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
